Literature DB >> 11162558

MDC-9 (ADAM-9/Meltrin gamma) functions as an adhesion molecule by binding the alpha(v)beta(5) integrin.

M Zhou1, R Graham, G Russell, P I Croucher.   

Abstract

MDC-9 is a widely expressed member of the metalloproteinase/disintegrin/cysteine-rich protein family. The disintegrin domain of MDC-9 lacks an RGD motif but has recently been reported to bind the alpha(6)beta(1) integrin; however, it is unclear whether MDC-9 can bind other integrins. In the present study myeloma cells, but not lymphoblastoid cells, were shown to bind to immobilised, recombinantly expressed MDC-9 disintegrin domain (A9dis). Binding was divalent cation-dependent, being supported by Mn(2+) and Ca(2+). Adhesion of myeloma cells to A9dis was completely inhibited by an antibody to the alpha(v)beta(5) integrin but not by antibodies to other subunits. RGD-containing peptides had no effect on binding, suggesting that MDC-9 interacts with alpha(v)beta(5) in an RGD-independent manner. Flow cytometric analyses demonstrated that myeloma cells, but not lymphoblastoid cells, expressed alpha(v)beta(5) on the cell membrane. These data indicated that the disintegrin domain of MDC-9 can function as an adhesion molecule by interacting with an alpha(v)beta(5) integrin. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162558     DOI: 10.1006/bbrc.2000.4155

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  Expression of ADAMs and their inhibitors in sputum from patients with asthma.

Authors:  Geneviève Paulissen; Natacha Rocks; Florence Quesada-Calvo; Philippe Gosset; Jean-Michel Foidart; Agnès Noel; Renaud Louis; Didier D Cataldo
Journal:  Mol Med       Date:  2006 Jul-Aug       Impact factor: 6.354

2.  ADAM-9 (MDC-9/meltrin-gamma), a member of the a disintegrin and metalloproteinase family, regulates myeloma-cell-induced interleukin-6 production in osteoblasts by direct interaction with the alpha(v)beta5 integrin.

Authors:  Abdullah Karadag; Min Zhou; Peter I Croucher
Journal:  Blood       Date:  2005-12-22       Impact factor: 22.113

3.  Sorting nexin 9 (SNX9) regulates levels of the transmembrane ADAM9 at the cell surface.

Authors:  Kasper J Mygind; Theresa Störiko; Marie L Freiberg; Jacob Samsøe-Petersen; Jeanette Schwarz; Olav M Andersen; Marie Kveiborg
Journal:  J Biol Chem       Date:  2018-04-05       Impact factor: 5.157

Review 4.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

5.  Phenotypic analysis of Meltrin alpha (ADAM12)-deficient mice: involvement of Meltrin alpha in adipogenesis and myogenesis.

Authors:  Tomohiro Kurisaki; Aki Masuda; Katsuko Sudo; Junko Sakagami; Shigeki Higashiyama; Yoichi Matsuda; Akira Nagabukuro; Atsushi Tsuji; Yoichi Nabeshima; Masahide Asano; Yoichiro Iwakura; Atsuko Sehara-Fujisawa
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

6.  The disintegrin-like and cysteine-rich domains of ADAM-9 mediate interactions between melanoma cells and fibroblasts.

Authors:  Paola Zigrino; Roswitha Nischt; Cornelia Mauch
Journal:  J Biol Chem       Date:  2010-12-06       Impact factor: 5.157

7.  Platelet integrin α6β1 controls lung metastasis through direct binding to cancer cell-derived ADAM9.

Authors:  Elmina Mammadova-Bach; Paola Zigrino; Camille Brucker; Catherine Bourdon; Monique Freund; Adèle De Arcangelis; Scott I Abrams; Gertaud Orend; Christian Gachet; Pierre Henri Mangin
Journal:  JCI Insight       Date:  2016-09-08

8.  MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells.

Authors:  Jose L R Brito; Brian Walker; Matthew Jenner; Nicholas J Dickens; Nicola J M Brown; Fiona M Ross; Athanasia Avramidou; Julie A E Irving; David Gonzalez; Faith E Davies; Gareth J Morgan
Journal:  Haematologica       Date:  2008-12-04       Impact factor: 9.941

9.  Recombinant disintegrin domain of human ADAM9 inhibits migration and invasion of DU145 prostate tumor cells.

Authors:  Ana Carolina Baptista Moreno Martin; Ana Carolina Ferreira Cardoso; Heloisa Sobreiro Selistre-de-Araujo; Márcia Regina Cominetti
Journal:  Cell Adh Migr       Date:  2015-07-25       Impact factor: 3.405

10.  Loss of the metalloprotease ADAM9 leads to cone-rod dystrophy in humans and retinal degeneration in mice.

Authors:  David A Parry; Carmel Toomes; Lina Bida; Michael Danciger; Katherine V Towns; Martin McKibbin; Samuel G Jacobson; Clare V Logan; Manir Ali; Jacquelyn Bond; Rebecca Chance; Steven Swendeman; Lauren L Daniele; Kelly Springell; Matthew Adams; Colin A Johnson; Adam P Booth; Hussain Jafri; Yasmin Rashid; Eyal Banin; Tim M Strom; Debora B Farber; Dror Sharon; Carl P Blobel; Edward N Pugh; Eric A Pierce; Chris F Inglehearn
Journal:  Am J Hum Genet       Date:  2009-04-30       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.